Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 17, 2007. The document serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding changes in interests in American Depositary Shares (ADSs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to insider trading disclosures and does not contain financial performance data.
Material Changes
The filing details the sale of ADSs by Mr. D Stout, a Person Discharging Managerial Responsibility, on December 14, 2007. The transactions are as follows:
- 3,761 ADSs sold at $53.22 per share.
- 9,148 ADSs sold at $53.14 per share.
Total ADSs sold in this notification: 12,909.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to Disclosure and Transparency Rule 3.1.4R(1)(a) regarding the notification of the aforementioned transactions.
Investor Verification Points
- Verify the total number of ADSs sold by Mr. D Stout (12,909 shares).
- Confirm the sale dates (December 14, 2007) and execution prices ($53.22 and $53.14).
- Note that this filing contains no financial results or strategic updates for the period.